| abstract |
Disclosed are compound of formula (I), wherein the substituents are as defined in the specification, and processes for their preparation. The compounds have apoB secretion/MTP inhibiting activity and concomitant lipid lowering activity and are useful in the treatment of atherosclerosis, pancreatitis, obesity, hypertriglyceridemia, hypercholesterolemia, hyperlipidemia, diabetes and type II diabetes. |